322 related articles for article (PubMed ID: 33610095)
1. Evaluation of an emergency department-based opioid overdose survivor intervention: Difference-in-difference analysis of electronic health record data to assess key outcomes.
Watson DP; Weathers T; McGuire A; Cohen A; Huynh P; Bowes C; O'Donnell D; Brucker K; Gupta S
Drug Alcohol Depend; 2021 Apr; 221():108595. PubMed ID: 33610095
[TBL] [Abstract][Full Text] [Related]
2. Results From the POINT Pragmatic Randomized Trial: An Emergency Department-Based Peer Support Specialist Intervention to Increase Opioid Use Disorder Treatment Linkage and Reduce Recurrent Overdose.
Watson DP; Tillson M; Taylor L; Xu H; Ouyang F; Beaudoin FL; O'Donnell D; McGuire AB
Subst Use Addctn J; 2024 Jul; 45(3):378-389. PubMed ID: 38258819
[TBL] [Abstract][Full Text] [Related]
3. Recovery opioid overdose team (ROOT) pilot program evaluation: A community-wide post-overdose response strategy.
Dahlem CHG; Scalera M; Anderson G; Tasker M; Ploutz-Snyder R; McCabe SE; Boyd CJ
Subst Abus; 2021; 42(4):423-427. PubMed ID: 33284095
[No Abstract] [Full Text] [Related]
4. Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose.
Weiner SG; Carroll AD; Brisbon NM; Rodriguez CP; Covahey C; Stringfellow EJ; DiGennaro C; Jalali MS; Wakeman SE
J Subst Abuse Treat; 2022 Aug; 139():108785. PubMed ID: 35537918
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids.
Winhusen T; Wilder C; Lyons MS; Theobald J; Kropp F; Lewis D
Drug Alcohol Depend; 2020 Nov; 216():108265. PubMed ID: 32919098
[TBL] [Abstract][Full Text] [Related]
6. Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.
Crystal S; Nowels M; Samples H; Olfson M; Williams AR; Treitler P
Drug Alcohol Depend; 2022 Mar; 232():109269. PubMed ID: 35038609
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Patient-Reported Naloxone Acquisition and Carrying With an Automated Text Messaging System After Emergency Department Discharge in Philadelphia.
Agarwal AK; Sangha HK; Spadaro A; Gonzales R; Perrone J; Delgado MK; Lowenstein M
JAMA Netw Open; 2022 Mar; 5(3):e223986. PubMed ID: 35323949
[TBL] [Abstract][Full Text] [Related]
8. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
[TBL] [Abstract][Full Text] [Related]
9. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of patterns of opioid overdose and interventions delivered at a tertiary hospital emergency department: impact of COVID-19.
Potaka KL; Freeman R; Soo D; Nguyen NA; Sim TF; Moullin JC
BMC Emerg Med; 2022 Apr; 22(1):62. PubMed ID: 35397487
[TBL] [Abstract][Full Text] [Related]
11. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
[TBL] [Abstract][Full Text] [Related]
12. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose.
Dora-Laskey A; Kellenberg J; Dahlem CH; English E; Gonzalez Walker M; Brummett CM; Kocher KE
Acad Emerg Med; 2022 Apr; 29(4):442-455. PubMed ID: 34962682
[TBL] [Abstract][Full Text] [Related]
13. Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation.
Belden C; Kopak A; Coules C; Friesen T; Hall J; Shukla S
J Subst Use Addict Treat; 2024 Jul; 162():209364. PubMed ID: 38626851
[TBL] [Abstract][Full Text] [Related]
14. Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal.
Kilaru AS; Liu M; Gupta R; Perrone J; Delgado MK; Meisel ZF; Lowenstein M
Am J Emerg Med; 2021 Sep; 47():154-157. PubMed ID: 33812332
[TBL] [Abstract][Full Text] [Related]
15. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
16. Naloxone Use Among Emergency Department Patients with Opioid Overdose.
Marco CA; Trautman W; Cook A; Mann D; Rasp J; Perkins O; Ballester M
J Emerg Med; 2018 Jul; 55(1):64-70. PubMed ID: 29776702
[TBL] [Abstract][Full Text] [Related]
17. Development of a take-home naloxone program at an urban academic emergency department.
Eswaran V; Allen KC; Cruz DS; Lank PM; McCarthy DM; Kim HS
J Am Pharm Assoc (2003); 2020; 60(6):e324-e331. PubMed ID: 32690447
[TBL] [Abstract][Full Text] [Related]
18. A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial.
Winhusen T; Wilder C; Kropp F; Theobald J; Lyons MS; Lewis D
Drug Alcohol Depend; 2020 Nov; 216():108270. PubMed ID: 32911132
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates.
Tabatabai M; Cooper RL; Wilus DM; Edgerton RD; Ramesh A; MacMaster SA; Patel PN; Singh KP
J Prim Care Community Health; 2023; 14():21501319221147246. PubMed ID: 36625264
[TBL] [Abstract][Full Text] [Related]
20. The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.
Klemperer EM; Wreschnig L; Crocker A; King-Mohr J; Ramniceanu A; Brooklyn JR; Peck KR; Rawson RA; Evans EA
J Subst Use Addict Treat; 2023 Sep; 152():209103. PubMed ID: 37311520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
